Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
NBER WORKING PAPER SERIES WHY IS END-OF-LIFE SPENDING SO HIGH? EVIDENCE FROM CANCER PATIENTS Dan Zeltzer Liran Einav Amy Finkels
Overall survival results from the phase III MONALEESA-2 trial of postmenopausal patients with HR+/HER2- advanced breast cancer
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Mark Stemmer - Manager - Samios | ZoomInfo.com
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
لزج شارع رئيسي معاصر salomon stemmer - iwdmke.org
Purging of Autologous Bone Marrow for Transplantation: The Protection and Selection of the Hematopoietic Progenitor Cell
Joy Salomon Corlobe, Actor, London
Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses
Herbert Loong on Twitter: "Amazing work @ZerAlona and colleagues! Thanks for leading the way for the entire world in confirming the importance of timely administration of #COVID19 vaccination in patients." / Twitter
White Matter Changes in Patients with Breast Cancer Treated with High-Dose Chemotherapy and Autologous Bone Marrow Support
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN https://t.co/BzobspfqNg" / Twitter